概览
The rapid evolution of drug development and technology, coupled with regulatory advances have created new opportunities and challenges in healthcare. It is critical for regulators, academia, patients, and industries to collaborate closely to ensure an evolving and robust regulatory ecosystem that enables accelerated and cost-effective access to innovative healthcare solutions. This year, DIA Singapore Annual Meeting aims to bring regulators, patient representatives and industries to share and discuss ways in cultivating synergies in clinical research and the regulatory environment to innovate healthcare in APAC. Come join us and be a part of the discussions to explore the challenges and actions that stakeholders in APAC can adopt to ensure transformations in the healthcare evolution.
项目委员会
-
Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
Roche, Singapore -
Helene Sou, MSc, RAC Director, Growth and Emerging Markets
Takeda, Singapore -
Audrey Ooi, MSc Head- Business Development
Clinical Research Malaysia, Malaysia -
Ellyne Setiawan, MPharm Head of Research & Development Quality (Asia Pacific),
Daiichi Sankyo Singapore Pte. Ltd., Singapore -
Jack Wong Founder
ARPA (Asia Regulatory Professionals Association) , Singapore -
Martin Lim, MBA, MS Co-Founder and CEO
ONWARD Health Research, Singapore -
Sannie S Foong Chong, PhD Senior Director, Global Regulatory Policy
MSD International, Singapore -
Senthil Sockalingam M.D, Head of IQVIA Biotech, JAPAC, Chief Medical Officer, IQVIA, APAC
IQVIA, Singapore -
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore -
Vicky Hsu Senior Vice President, Head of Project Leadership and Biotech Operations Asia
Parexel International, Singapore -
Shogo Nakamori, MBA, MSc, RPh Senior Vice President & Managing Director, Japan, Korea, Singapore and Southeast
DIA, Japan -
Carley Kim, MBA Country Manager of Korea & Singapore
DIA, United States -
Jing Ping Yeo, PhD Head - Transformation
George Clinical, Singapore -
Fengyun(Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore -
Shun Jin, MBA Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore -
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Seasea GAO, MD, PhD Executive Medical Director
JAPAC Merck, Singapore
